GlassScriptPhysician profile
George L Cain
NPI 1790709079
$781.90
in general payments reported to CMS, 2019-2025
13 companies · $32.63 in 2025
The $32.63 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.40 · 2020: $163 · 2021: $223 · 2022: $142 · 2023: $35.91 · 2024: $96.63 · 2025: $32.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $165.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $259.95 | 2021-2022 | |
| Allergan, INC. | $147.18 | 2020 | |
| Astellas Pharma US INC | $85.00 | 2021 | |
| Sunovion Pharmaceuticals INC. | $62.08 | 2019 | |
| Janssen Pharmaceuticals, INC | $57.79 | 2024 | Xarelto |
| Kowa Pharmaceuticals America, INC. | $41.15 | 2022-2023 | Seglentis |
| Otsuka America Pharmaceutical, INC. | $36.15 | 2023-2024 | Rexulti |
| Novo Nordisk INC | $18.59 | 2025 | |
| Ucb, INC. | $18.23 | 2024 | Nayzilam |
| Edwards Lifesciences Corporation | $15.42 | 2020 | |
| Mylan Specialty L.P. | $15.20 | 2019 | |
| Alpha Cognition USA, INC. | $14.04 | 2025 | Zunveyl |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Cain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.